FTSE 100
8.414,46
PKT
+7,02
PKT
+0,08
%
Werbung
Analysen zu FTSE 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
02.04.24 | Barclays Buy | Jefferies & Company Inc. | |
02.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
28.03.24 | easyJet Overweight | JP Morgan Chase & Co. | |
28.03.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
28.03.24 | Reckitt Benckiser Overweight | Barclays Capital | |
28.03.24 | Reckitt Benckiser Buy | UBS AG | |
28.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
28.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
27.03.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
27.03.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.03.24 | International Consolidated Airlines Buy | Goldman Sachs Group Inc. | |
27.03.24 | International Consolidated Airlines Overweight | JP Morgan Chase & Co. | |
27.03.24 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.03.24 | HSBC Equal Weight | Barclays Capital | |
25.03.24 | Rio Tinto Buy | Deutsche Bank AG | |
25.03.24 | Rolls-Royce Buy | Deutsche Bank AG | |
25.03.24 | AstraZeneca Sell | UBS AG | |
25.03.24 | HSBC Neutral | UBS AG | |
25.03.24 | Unilever Sell | UBS AG | |
22.03.24 | Rolls-Royce Overweight | Barclays Capital | |
21.03.24 | Rolls-Royce Buy | Goldman Sachs Group Inc. | |
21.03.24 | Rolls-Royce Buy | UBS AG | |
21.03.24 | International Consolidated Airlines Outperform | RBC Capital Markets | |
20.03.24 | GSK Buy | Jefferies & Company Inc. | |
19.03.24 | Unilever Underperform | Jefferies & Company Inc. | |
19.03.24 | easyJet Overweight | JP Morgan Chase & Co. | |
19.03.24 | Unilever Underweight | JP Morgan Chase & Co. | |
19.03.24 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
19.03.24 | Unilever Sell | UBS AG | |
19.03.24 | Unilever Overweight | Barclays Capital | |
19.03.24 | Vodafone Group Equal Weight | Barclays Capital | |
19.03.24 | Unilever Market-Perform | Bernstein Research | |
19.03.24 | Diageo Outperform | Bernstein Research | |
19.03.24 | AstraZeneca Sell | UBS AG | |
19.03.24 | Unilever Sector Perform | RBC Capital Markets | |
19.03.24 | Reckitt Benckiser Buy | UBS AG | |
19.03.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
19.03.24 | GSK Buy | UBS AG | |
19.03.24 | Rolls-Royce Buy | Jefferies & Company Inc. | |
18.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.